Zenas, Bicara set out to raise $180M+ in separate IPOs to fund autoimmune, cancer prospects

Zenas, Bicara set out to raise $180M+ in separate IPOs to fund autoimmune, cancer prospects jwaldron Fri, 09/06/2024 - 06:58